In 2002 several large-scale clinical studies were published on the risks of breast cancer in postmenopausal women using conventional FDA-approved hormone therapy. These were the Women’s Health Initiative (WHI) and Million Women’s studies of women using FDA-approved estrogens and progestogens in the United States and Great Britain, respectively. Both studies came to the same conclusion – that…
Tags: Progesterone, Estrogen, Menopause, Breast Cancer, Brain Health
![Topical Progesterone, Not Synthetic Progestins or Oral Progesterone, Should Be Considered as a Companion for Estradiol Replacement Therapy](/media/2497/topical-progesterone-as-companion-for-estradiol-replacement-therapy.jpg?anchor=center&mode=crop&width=300&height=200&rnd=132264956490000000)